Background: Many signals are transduced from the cell surface to the nucleus through mitogen-activated protein (MAP) kinase cascades. Activation of MAP kinase requires phosphorylation by MEK, which in turn is controlled by Raf, Mos or a group of structurally related kinases termed MEKKs. It is not understood how MEKKs are regulated by extracellular signals. In yeast, the MEKK Ste11p functions in multiple MAP kinase cascades activated in response to pheromones, high osmolarity and nutrient starvation. Genetic evidence suggests that the p21-activated protein kinase (PAK) Ste20p functions upstream of Ste11p, and Ste20p has been shown to phosphorylate Ste11p in vitro.
Phosphorylation of the MEKK Ste11p by the PAK-like kinase Ste20p is required for MAP kinase signaling in vivo
Frank van Drogen*, Sean M. O'Rourke † , Volker M. Stucke*, Malika Jaquenoud*, Aaron M. Neiman ‡ and Matthias Peter* Background: Many signals are transduced from the cell surface to the nucleus through mitogen-activated protein (MAP) kinase cascades. Activation of MAP kinase requires phosphorylation by MEK, which in turn is controlled by Raf, Mos or a group of structurally related kinases termed MEKKs. It is not understood how MEKKs are regulated by extracellular signals. In yeast, the MEKK Ste11p functions in multiple MAP kinase cascades activated in response to pheromones, high osmolarity and nutrient starvation. Genetic evidence suggests that the p21-activated protein kinase (PAK) Ste20p functions upstream of Ste11p, and Ste20p has been shown to phosphorylate Ste11p in vitro.
Results: Ste20p phosphorylated Ste11p on Ser302 and/or Ser306 and Thr307 in yeast, residues that are conserved in MEKKs of other organisms. Mutating these sites to non-phosphorylatable residues abolished Ste11p function, whereas changing them to aspartic acid to mimic the phosphorylated form constitutively activated Ste11p in vivo in a Ste20p-independent manner. The amino-terminal regulatory domain of Ste11p interacted with its catalytic domain, and overexpression of a small amino-terminal fragment of Ste11p was able to inhibit signaling in response to pheromones. Mutational analysis suggested that this interaction was regulated by phosphorylation and dependent on Thr596, which is located in the substrate cleft of the catalytic domain.
Conclusions:
Our results suggest that, in response to multiple extracellular signals, phosphorylation of Ste11p by Ste20p removes an amino-terminal inhibitory domain, leading to activation of the Ste11 protein kinase. This mechanism may serve as a paradigm for the activation of mammalian MEKKs.
Background
Extracellular and intracellular stimuli control cell proliferation and morphological changes, and are important elements governing development of multicellular organisms. Many signals are transduced by mitogen-activated protein (MAP) kinase modules, which consist of a kinase cascade of at least three kinases acting sequentially [1] ; MAP kinases are activated by phosphorylation by the MAP kinase kinase MEK, which in turn is phosphorylated and activated by Raf, Mos or a group of structurally related kinases termed MEKK. Several MAP kinase modules have been identified including the extracellular signal-regulated kinase (ERK)-type modules, the Jun N-terminal kinase (JNK) or stressactivated protein kinase (SAPK) modules and the kinases of the p38 family. Some MAP kinase modules are bound to scaffold molecules such as JIP1, which are thought to be required for MAP kinase activation and may contribute to specificity of signal transduction [2, 3] .
Saccharomyces cerevisiae uses five MAP kinase modules which mediate cellular responses during mating and sporulation, and allow cells to adapt rapidly to changes in the environment such as high osmolarity, cell integrity, starvation and filamentous growth [4] . In the mating pathway, binding of pheromones to a seven-transmembrane receptor leads to dissociation of the heterotrimeric G protein, allowing Gβγ to interact with the downstream effectors Ste5p [5] [6] [7] [8] and Ste20p [9] . Ste5p is required to transduce the signal and it interacts with the MEKK Ste11p, the MEK Ste7p and the MAP kinase Fus3p, suggesting that it functions as an adaptor for the mating pathway [10] . In the nucleus, Fus3p phosphorylates the repressors Dig1p and Dig2p [11, 12] , leading to their dissociation from the transcriptional activator Ste12p. Ste11p is also required for signal transduction in response to high extracellular osmolarity and filamentous growth conditions [4] . In the high osmolarity pathway, Ste11p is part of a MAP kinase module composed of Pbs2p and Hog1p, while nutrient starvation triggers the formation of pseudohyphae by activating the MAP kinase Kss1p.
Despite the detailed knowledge of MAP kinase modules, their upstream activating mechanisms are poorly understood. Genetic epistasis analysis in yeast and studies in mammalian systems indicate that Ste20p and other kinases similar to the p21-activated kinase (PAK-like kinases) function upstream of MEKKs such as Ste11p [13] . PAK-like kinases are activated by the small GTPases Cdc42p or Rac1p [14] and are known to control gene expression in the nucleus and cytoskeletal events. In mammalian cells, activation of Cdc42p stimulates the JNK/p38 subgroup of MAP kinases and also, in some cell types, the ERK pathway [15, 16] . Pak3 has been shown to phosphorylate Raf-1 [17] , suggesting that PAK-like kinases are required for maximal activation of Raf by Ras. Similarly, in yeast, purified Ste20p is able to phosphorylate Ste11p in vitro [18] , indicating that phosphorylation of Ste11p may be involved in its activation in vivo. The kinase activity of purified Ste11p is not altered by pheromone treatment, suggesting that pheromones may not increase its catalytic activity per se but may regulate the subcellular localization of Ste11p or its interaction with an inhibitory protein [19] . Finally, Ste50p is able to bind the amino-terminal domain of Ste11p [20, 21] ; ste50∆ cells exhibit multiple signaling defects [22] [23] [24] , suggesting that Ste50p functions as an activator of Ste11p in vivo.
Here, we have investigated the functional significance of Ste11p phosphorylation by Ste20p. We found that Ste20p phosphorylated three conserved sites in the amino terminus of Ste11p, and mutational analysis indicated that phosphorylation of these sites was required to activate Ste11p in vivo in response to pheromones, high osmolarity and pseudohyphal growth conditions. Our results strongly suggest that phosphorylation relieves inhibition of the catalytic domain, which is exerted intramolecularly by its own amino-terminal regulatory domain. Taken together, our results provide a molecular mechanism for the activation of Ste11p by Ste20p in response to extracellular signals, which may serve as a paradigm for the activation of mammalian MEKKs.
Results

Ste11p is phosphorylated in vivo in a STE20-dependent manner
To examine whether Ste11p is phosphorylated in vivo, wild-type cells expressing a kinase-inactivated form of Ste11p (Ste11p-K444R) fused to gluthathione-S-transferase (GST) were labeled with 32 P-orthophosphate and either treated or not treated with α-factor. Ste11p was then purified using GST affinity beads (Figure 1a) . In response to α-factor, GST-Ste11-K444R was readily phosphorylated (lanes 3,4), predominantly on serine residues (Figure 1c , left panel). In vivo, phosphorylation of GST-Ste11-K444R was dependent on Ste20p (lane 5); in vitro, purified Ste20p (Figure 1b, lane 6 ), but not a kinase-inactivated form of Ste20p (Ste20p-K649R; lane 7), was able to phosphorylate GST-Ste11-K444R, suggesting that Ste20p may directly phosphorylate Ste11p. Deletion analysis indicated that residues primarily in the amino-terminal regulatory domain of Ste11p were phosphorylated (data not shown), and within this region, Ste11p-like kinases from several species contain a conserved motif with serine and threonine residues (Figure 1d ). To test whether these residues were phosphorylated by Ste20p, we mutated them to non-phosphorylatable alanine residues (Ste11p-Ala3) and expressed wild-type or mutant Ste11 proteins as GST fusions in Escherichia coli. Purified Ste20p was unable to phosphorylate GST-Ste11p 175-424 -Ala3 (Figure 1e, lane 3) , whereas wild-type GST-Ste11p 175-424 was phosphorylated (lane 2), indicating that Ser302 and/or Ser306 and Thr307 are phosphorylated by Ste20p in vitro. Importantly, phosphorylation of full-length GST-Ste11p-Ala3 was strongly reduced in 32 P-orthophosphate-labeled cells treated with α-factor (Figure 1e ), suggesting that these sites are indeed phosphorylated in vivo in response to pheromones.
Phosphorylation of Ste11p is functionally relevant in vivo
To examine whether phosphorylation of these sites is biologically relevant in vivo, we transformed ste11∆ cells (YMP518) with either a control plasmid (vector) or plasmids expressing, from the endogenous promoter, wildtype Ste11p, Ste11p-Ala3 or Ste11p in which Ser302, Ser306 and Thr307 were mutated to aspartic acid (Ste11p-Asp3; see below) and determined the ability of these cells to respond to pheromones, assayed by arrest of the cell cycle, induction of the transcriptional reporter FUS1-lacZ, and mating (Figure 2a-c) . Although the Ste11p-Ala3 protein was expressed at wild-type levels (Figure 3a ; data not shown), the mutated protein was unable to function in the pheromone response pathway, indicating that phosphorylation of these residues is important for activation of Ste11p in vivo. In contrast, plasmids containing STE11 harboring single mutations in any of these sites functioned efficiently in all assays (data not shown), suggesting that more than one of the residues needs to be phosphorylated to fully activate Ste11p in vivo. Wild-type cells overexpressing Ste11p-Ala3 exhibited poor induction of the FUS1-lacZ reporter ( Figure 3c ) and failed to arrest the cell cycle in response to pheromones (Figure 3b ), suggesting that overexpression of Ste11p-Ala3 acts in a dominantnegative fashion to interfere with Ste11p function. We conclude that phosphorylation of Ser302 and/or Ser306 and Thr307 is required for Ste11p function in vivo. To determine whether phosphorylation was sufficient to activate Ste11p in vivo, we mutated these residues to aspartic acid residues in an attempt to mimic the phosphorylated form of Ste11p (Ste11p-Asp3). Interestingly, overexpression of Ste11p-Asp3 but not kinase-inactive Ste11p-Asp3-K444R resulted in activation of the mating pathway in the absence of pheromones (Figure 2d,e) . Importantly, activation of the mating pathway by Ste11p-Asp3 required Ste7p but was independent of Ste20p ( Figure 2f ), consistent with the idea that Ste20p phosphorylates and thereby activates Ste11p. Taken together, these results suggest that phosphorylation of Ser302 and/or Ser306 and Thr307 is necessary and sufficient for activation of Ste11p in vivo.
Ste11p not only functions in the mating pathway but is also required to signal in response to high osmolarity and during pseudohyphal growth [4] . Nutrient starvation triggers the formation of pseudohyphae by activating the MAP kinase Kss1p in a STE20-dependent manner [25] . Interestingly, ste11∆ cells expressing Ste11p-Ala3 from the endogenous promoter were unable to form pseudohyphae (Figure 4a ; middle panel), whereas wild-type Ste11p (left panel) or Ste11p-Asp3 (right panel) complemented the defect, suggesting that phosphorylation of Ste11p by Ste20p is required for pseudohyphal growth. In the high osmolarity response pathway, Ste11p is part of a MAP kinase module composed of Pbs2p and Hog1p. In addition, high osmolarity conditions also activate Hog1p independently of Ste11p by a pathway that requires Ssk1p [26, 27] . Addition of NaCl induced phosphorylation of the MAP kinase Hog1p on Tyr176 in ste11∆ ssk1∆ cells (SO419) expressing wild-type Ste11p, but not in ste11∆ ssk1∆ cells expressing Ste11p-Ala3 (Figure 4b , lower panel), suggesting that phosphorylation of Ste11p is required to activate Hog1p in response to high osmolarity. As expected, expression of Ste11p-Ala3 failed to restore growth of ste11∆ ssk1∆ cells on high osmolarity medium ( Figure 4c ). When Ste11p-Asp3 was overexpressed, tyrosine phosphorylation ( Figure 4b , upper panel) and nuclear localization of Hog1p (data not shown) was detected even in the absence of high salt, demonstrating that Ste11p-Asp3 was able to constitutively activate both the high osmolarity and pheromone response pathways. Consistent with these results, cells overexpressing Ste11p-Asp3 exhibited a growth defect, which was rescued only by simultaneous deletion of Ste7p and Pbs2p (Figure 4d ). Thus, these results indicate that phosphorylation of Ste11p is required to transduce the signal in several MAP kinase modules. Importantly, in all these situations, Ste20p is thought to function upstream of Ste11p, suggesting that Ste20p directly activates Ste11p in multiple signaling pathways.
The amino terminus of Ste11p binds its carboxy-terminal domain in a phosphorylation-dependent manner
Overexpression of an amino-terminal deletion of Ste11p constitutively activates the mating pathway, suggesting that the amino-terminal domain exerts an inhibitory function [28, 29] . To determine whether the amino terminus directly inhibits the catalytic domain, we first determined whether the amino-terminal domain binds the catalytic domain. Wild-type Ste11p 1-424 readily coimmunoprecipitated with its catalytic domain (Figure 5a ), and the wildtype or Ala3-amino-terminal domain was able to interact with the catalytic domain in a two-hybrid assay (Figure 5b ). This interaction was also observed in ste5∆ cells (YFD229; data not shown), excluding the possibility that Ste5p bridges binding of the two domains. Interestingly, the amino-terminal fragment of the Ste11p-Asp3 mutant failed to interact with the catalytic domain (Figure 5b ), whereas all three amino-terminal constructs were able to interact with Ste5p and Ste50p (Figure 6b) . Moreover, the catalytic domain of the constitutive allele STE11-4, which harbors a threonine to isoleucine mutation (T596I) in the catalytic domain [28] , was defective for binding to the wild-type regulatory domain (Figure 5b ), demonstrating that residues in both the amino-terminal and the catalytic domains are required for the interaction. Taken together, these results suggest that phosphorylation of the amino-terminal domain of Ste11p prevents binding to its catalytic domain, thereby leading to activation of the kinase (Figure 5c ). These results do not, however, exclude the possibility that phosphorylation of the amino-terminal domain of Ste11p controls binding to as yet unidentified regulators that may either inhibit or activate the kinase.
To test these models further, we examined the pheromone response of wild-type cells expressing different fragments of the amino-terminal inhibitory domain of Ste11p ( Figure 6 ). We found that overexpression of Ste11p potently prevented halo formation ( Figure 6c) ; however, at least when assessed by mutational analysis, inhibition was independent of the phosphorylation state of the fragment, suggesting that this effect was not solely due to binding its catalytic domain. Because the Ste11p activators Ste5p and Ste50p bound with comparable efficiency to the phosphorylated (Ste11p-Asp3) or non-phosphorylated (Ste11p-Ala3) amino-terminal domain of Ste11p (Figure 6b ), we believe that Ste11p 1-424 inhibits signal transduction in response to pheromones by blocking access of wild-type Ste11p to Ste5p and/or Ste50p. In contrast, Ste11p was unable to interact with Ste5p and Ste50p (Figure 6a ), but was able to inhibit halo formation in a phosphorylationdependent manner (Figure 6c ), suggesting that Ste11p inhibits the catalytic domain of Ste11p in vivo. Thus, we propose that the amino-terminal domain of Ste11p prevents activation of wild-type Ste11p in response to pheromones in at least two ways: first, it blocks binding of Ste11p to the activators Ste5p and Ste50p, and second, it binds and thereby inhibits its catalytic domain.
Discussion
Despite the general importance of MAP kinase pathways, it is not understood how these modules are activated in response to extracellular signals. Here, we have provided 
to its catalytic domain. Taken together, our results suggest a molecular mechanism for the activation of Ste11p, and support the idea that Ste20p may directly activate Ste11p in vivo.
Ste20p may phosphorylate and thereby regulate Ste11p in vivo
Our results suggest that Ste20p is a direct activator of Ste11p. Ste20p functions upstream of Ste11p in the signaling pathways triggered by pheromones, high osmolarity or low nitrogen conditions [4] . Phosphorylation of Ste11p in vivo is induced by pheromones in a STE20-dependent manner, suggesting that Ste20p is needed to phosphorylate Glucose Galactose Ste11p in vivo. Nevertheless, this result does not exclude the possibility that Ste11p may be phosphorylated by a kinase functioning downstream of Ste11p by a feedback mechanism, as has been observed for Ste7p [30, 31] . Purified Ste20p phosphorylated Ste11p on Ser302 and/or Ser306 and Thr307, and a Ste11p mutant protein lacking these sites was no longer phosphorylated in vivo. Interestingly, these residues are located in the regulatory domain of Ste11p and comprise a motif that is conserved in MEKKs from several species. Ser302 contains a K/Rcharged residue at the -3 position, consistent with the substrate consensus sequence established for PAK-like kinases using an oriented peptide library [32] . The sites also resemble Ser308 on Raf-1, which is phosphorylated by PAK3 [17] , but varies slightly from the consensus sequence deduced for phosphorylation of myosin I [33, 34] . As more phosphorylation sites for PAK-like kinases are discovered, it may be possible to identify a more accurate substrate consensus site for PAK-like kinases.
The sites phosphorylated by Ste20p in vitro are required for Ste11p function in vivo. Our results are mainly based on mutational analysis and we have not rigorously shown that these sites are indeed phosphorylated in a pheromonedependent manner. Several lines of evidence strongly argue against a solely structural role of this motif. First, although mutating these amino acids to alanine residues abolished Ste11p function, changing these residues to aspartic acid constitutively activated the kinase in vivo. Second, all Ste11p mutants were able to interact with Ste5p and Ste50p, which both bind to the regulatory domain of Ste11p. Third, the Ste11p-Ala3 regulatory domain interfered with signaling in vivo in a dominant-negative manner and was able to interact with its catalytic domain. Finally, phosphorylation of more than one of these residues was necessary for full activation of Ste11p; mutations that changed only Ser302 or Ser306 into alanine residues were still able to restore the mating defect of ste11∆ cells (data not shown). In addition, changing Ser302 to aspartic acid led only to a very weakly activated form of Ste11p. Taken together, these results strongly argue that phosphorylation of these residues by Ste20p is required to regulate the function of Ste11p in vivo. Ste20p localizes to the plasma membrane by either binding to the small GTPase Cdc42p [35, 36] or the Gβγ heterodimer of the activated G protein [9] . To allow efficient phosphorylation of Ste11p by Ste20p, it is thus likely that Ste11p must be targeted to the plasma membrane. In the mating pathway, Ste11p binds to Ste5p, which is recruited to the plasma membrane in response to pheromones by binding to Gβγ [5] [6] [7] [8] , suggesting that Ste5p may bring Ste11p into close proximity of Ste20p, thereby allowing its phosphorylation. In response to high osmolarity or filamentous growth conditions, recruitment of Ste20p to the plasma membrane requires Cdc42p [23, 35, 36 ], but it is not known how Ste11p is targeted to Ste20p in these pathways [24] .
Phosphorylation of Ste11p by Ste20p may release the intramolecular inhibition of its catalytic domain
Our studies suggest a mechanism whereby Ste20p activates Ste11p in vivo. We propose that, in the absence of a signal, the amino-terminal regulatory domain of Ste11p inhibits the catalytic domain, thereby keeping the kinase inactive (Figure 5c ). Consistent with this model, the amino-terminal domain of Ste11p was unable to interact with full-length Ste11p-Ala3, suggesting that the catalytic domain is quantitatively bound to its regulatory domain in the absence of activating signals (data not shown). Binding of the inhibitory domain requires residues adjacent to the DFG motif [37] , which is located in the deep cleft between the two lobes of the kinase structure [38] . Interestingly, several kinase inhibitors including the drug H7 have been shown to bind to this position [39] , suggesting that the amino-terminal domain of Ste11p may reach into the cleft and directly inhibit substrate binding or catalysis. Consistent with this model, overexpression of a non-phosphorylatable mutant form interfered with Ste11p function in a dominant-negative manner. In the mating pathway, this dominant-negative effect is mediated by at least two mechanisms. First, the amino-terminal domain binds to Ste5p and Ste50p in a phosphorylation-independent manner, and may thus block access of wild-type Ste11p to its activators. Second, the amino-terminal domain of Ste11p binds to its The amino-terminal fragments of wild-type or mutant forms of Ste11p were fused to the LexA DBD and expressed with full-length Ste5p or Ste50p fused to the Gal4 AD. Two-hybrid assays were performed as described [47] (Figure 5c ). The phosphorylated residues may directly bind to the DFG loop, or phosphorylation may induce a structural change that prevents interaction of the inhibitory domain with the substrate cleft. Although we cannot exclude the possibility that phosphorylation of Ste11p may also regulate binding of as yet unknown regulators or influence its subcellular localization or stability, the finding that mutations in both the regulatory (STE11-ASP3) and catalytic domain (STE11-4) of Ste11p abolished their interaction and constitutively activated the kinase in vivo is consistent with our model of intramolecular inhibition. Finally, genetic experiments suggest that Ste20p cooperates with Ste50p to activate Ste11p [20] (data not shown), and Ste50p interacts with the amino-terminal region of Ste11p [20, 21, 40] in a phosphorylation-independent manner (Figure 6b ). It has been proposed that Ste50p interferes with the interaction between the amino-terminal and the catalytic domain of Ste11p [20] , and overexpression of Ste50p was able to suppress the mating defect of ste20∆ cells (data not shown). Thus, binding of the amino-terminal domain of Ste11p to Ste50p and phosphorylation by Ste20p may together abolish its interaction with the catalytic domain of Ste11p, leading to full activation of the kinase.
PAK-like kinases: general activators of MEKKs?
In a number of species, PAK-like kinases are known to activate MAP kinase signaling pathways in a manner analogous to that in yeast [1] . In Drosophila, the Ste20/PAK-like kinase misshapen (msn) is required upstream of a MAP kinase cascade involved in dorsal closure during late stages of embryogenesis [41] , and may function downstream of the Frizzled receptor in planar polarity signaling [42] . Likewise, a constitutive form of human PAK1 is sufficient to activate the JNK pathway in mammalian cells [43] . The substrates of PAK-like kinases in these signaling pathways are not known, but it has recently been found that PAK3 phosphorylates mammalian Raf-1 on a site which is functionally important in vivo [17] , suggesting that mammalian PAK-like kinases, like their yeast counterparts, may directly phosphorylate and activate MEKKs and members of the Raf family of protein kinases. Phosphorylation of human MEKK1 is observed in response to genotoxic agents, and deletion of the amino-terminal regulatory domain of MEKK1 kinases renders the kinase constitutively active [44, 45] , suggesting that mammalian MEKKs may similarly be regulated by intramolecular inhibition. Interestingly, the amino-terminal domain of MEKK1 is cleaved by caspase 3, which may constitutively activate the kinase in apoptotic cells [44, 45] . Thus, it is possible that phosphorylation of the amino-terminal domain may reversibly relieve intramolecular inhibition of MEKK1, while the kinase may be irreversibly activated by proteolytic processing of the regulatory domain. Taken together, our results provide a possible molecular mechanism for the activation of MEKKs, and strongly support the idea that PAK-like kinases function as direct activators of MEKKs in multiple MAP kinase pathways.
Materials and methods
Strains, media and genetic techniques
Standard yeast growth conditions were used as described [46] . NaCl (Sigma) was used at a final concentration of 1 M as indicated. For α-factor treatment, cells were grown in liquid YEPD or synthetic medium, and α-factor in 0.001 M HCl was added to a final concentration of 0.005 mg/ml. Yeast strains were derived from the W303 (ade2-1 trp1-1 leu2-3,112 ura3 his3-11,15 can1-100) or EG123 (trp1-1 leu2-3,112 ura3 his4 can1) background. Gene disruptions were confirmed by phenotypic analysis and/or PCRs with gene-specific primers.
Plasmid construction and site-directed mutagenesis
Standard molecular biology techniques were used [47] . Full-length or amino-terminal fragments of STE11 were amplified by PCR using genomic DNA as a template, digested with BamHI and XhoI and ligated into pRD53 or pRD56, which allows expression of Ste11p or GST-Ste11p from the inducible GAL promoter. The following primers were used: full-length STE11, oTP438 (5′-CCTCTCGAGGAAAGGC-CTGTTTCTTCGTGCTT-3′) and oTP439 (5′-TTCGGATCCACACA-CATGCATAAAGAGAGACC-3′); STE11 , oTP476 (5′-ATATG-GATCCACATGCATAAAGAGAGACC-3′) and oTP477 (5−GCGTCTC-GAGTTACGTCGGTAATGAAACAATG-3′); STE11 , oTP644 (5′-ATAGGATCCACTATGTACCTGGATAGC-3′) and oTP649 (5′-CGTTCTCGAGTTACAATAGTATGTCACCG-3′); STE11(174-353), oTP646 (5′-CATGGATCCACTATGGCCACAAACTCCAATGGAG-3′) and oTP649. Wild-type and mutant forms of full-length STE11 were also cloned under the control of the STE11 promoter, which was amplified with the primers oTP662 (5′-TCTAGGTTGCGGC-CGCAGTAGTCCACCAAAGCAGGG-3′) and oTP566 (5′-TGTG-GATCCGAATATTTTCTACTGTTTAAAGCC-3′), introducing NotI and BamHI restriction sites. Oligo site-directed mutagenesis was carried out with the primers oTP446 (5′-CAGAGGCCTCCGGCCGAATT-TATTGCTGCCAATTTGGCCGG-3′) and oTP447 (5′-CAGAGGCCT-GACGAATTTATCGATGACAATTTGGCCGG-3′) using the ExSite kit (Stratagene) as recommended by the manufacturer. The mutations introduce EagI and ClaI restriction sites and were verified by sequencing. DNA sequences encoding residues 175-424 of Ste11p were amplified by PCR using the primers oTP523 (5′-CGCGGGATCCTTAGCCA-CAAACTCC-3′) and oTP477 (5′-GCGTCTCGAGTTACGTCGGTAAT-GAAACAATGTC-3′), digested with XhoI and BamHI and cloned into pGEX-4T (Pharmacia).
Two-hybrid assays
Two-hybrid assays were performed in yeast strain EGY48, YMP290 (bar1-1 far1∆) or YFD229 (bar1-1 ste5∆) using pEG202-based plasmids expressing LexA DNA-binding domain fusions (DBD), and pJG4-5-based plasmids containing fusions to the B42 transcriptional activation domain (AD) [24] . Plasmids pEG203 and pJG4-6 are derivatives of pEG202 and pJG4-5, respectively, with an altered polylinker (kind gift of E. O'Shea). The regulatory domain of STE11 was amplified by PCR with the primers oTP476 and oTP477 and cloned as a BamHI-XhoI fragment into pEG202, whereas the catalytic domain of STE11 or STE11-4 was amplified with the primers oTP475 (5′-ATTGTTGAATTCCCGACGAAAATTGCCACGCCC-3′) and oTP438 and cloned as a EcoRI-XhoI fragment into pJG4-5. The fulllength STE11 coding sequence was amplified by PCR with the primers oTP476 and oTP438 using genomic DNA as a template, digested with BamHI and XhoI, and ligated into pEG202 and pJG4-5, respectively. Full-length STE50 and STE5 were amplified as above using primers oTP494 (5′-GCAGAATTCATGGAGGACGGTAAACAGGC-3′) and oTP510 (5′-TCCCTCGAGCAAACATGAAAATAAGGCCAAGCC-3′), or oTP564 (5′-TTTCCCATGGTGGAAACTCCTACAGACAATATA-GTTTCC-3′) and oTP565 (5′-CTAAGAAGAACTGGGCCCACTTCA-AATTCACGG-3′). The fragments were digested with EcoRI and XhoI, and NcoI and ApaI, respectively, and ligated into pJG4-5 or pJG4-6. LacZ reporter activity was measured as described previously [48] ; averages and standard deviations were determined from at least three independent experiments. When possible, two-hybrid interactions were confirmed with both DNA-and activation domain fusions.
Sequence alignments and structural analysis
Database searches were performed using SGD (Stanford University) and the NCBI BLAST programs (NIH). The structural coordinates were downloaded from the protein database (http://www.rcsb.org/pdb/.) and analyzed using Swiss-PDB Viewer [49] .
Mating, cell-cycle arrest, FUS1-lacZ, and pseudohyphal growth assays
Cell-cycle arrest, morphology and mating assays were carried out as described [50] . Mating assays were performed with the tester strains IH2625 (MATα lys1 far1-c) and IH1793 (MATα lys1). Cells deleted for STE11 (YMP518) were transformed with plasmids expressing wildtype or mutant Ste11p from endogenous or the GAL promoter and assayed either on medium containing glucose (2% final concentration, low expression levels of Ste11p) or galactose (2% final concentration, high expression levels of Ste11p). The FUS1::lacZ::LEU2 integrating reporter gene, from plasmid pFC23 [23] , was introduced into wild-type or strains containing mutations in STE genes as indicated; lacZ expression was measured as described previously [50] . Pseudohyphal growth assays were carried out on SLAD medium as described [23] . Colonies were photographed after three days.
Western blots, antibodies and detection of phosphorylated Hog1p
Protein extracts and immunoblots were carried out as described previously [51] . Phosphorylated Hog1p was assayed as described [23] using the anti-phospho-specific p38 antibody (New England Biolabs). Nuclear translocation of Hog1p-GFP was observed as described [52] .
Coimmunoprecipitation experiments, purification of GST proteins and in vitro kinase assays
Coimmunoprecipitation experiments were carried out with monoclonal HA antibodies (11HA; Babco) as described previously [53] ; cells carrying a plasmid encoding the catalytic domain of Ste11p fused to GST (pDP901), and either a control plasmid expressing GST (pRD56) or plasmids expressing wild-type or mutant forms of the HA-tagged regulatory domain (pFD196) from the inducible GAL promoter were used. GST fusions to the amino-terminal domain of wild-type or mutant Ste11p were expressed in E. coli (DH5α) and purified using standard procedures [54] . Purification of wild-type and kinase-inactive Ste20p from yeast and kinase assays were carried out as described [35] .
P-orthophosphate labeling and purification of phosphorylated GST-Ste11p from yeast
Cells expressing either GST, GST-Ste11p-K444R or GST-Ste11p-Ala3 from the inducible GAL promoter were grown to mid-log phase at 30°C in synthetic medium containing 2% galactose. Cells were then washed twice with phosphate-depleted medium [55] and grown for an additional 2 h in phosphate-depleted medium at 30 ο C. Cells were concentrated by centrifugation, resuspended in phosphate-depleted medium containing 32 P-orthophosphate (500 µCi/ml; New England Nuclear) and, where indicated, 10 µM α-factor, and labeled for 30 min at 30 ο C. Cells were pelleted, washed with ice-cold phosphate-buffered saline (PBS: 8.1 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 137 mM NaCl, 2.7 mM KCl, pH 7.2) and lysed in ice-cold RIPA buffer (50 mM Tris pH 8.0, 50 mM NaCl, 1% NP40, 0.5% deoxycholate, 0.1% SDS) using glass beads. Extracts were incubated with glutathione beads for 30 min, washed extensively with ice-cold RIPA supplemented with free phosphate, and bound proteins were eluted in PBS containing 10 mM glutathione. Phosphorylated proteins were analyzed by SDS-PAGE and autoradiography. Phospho-amino acid analysis of Ste11p was carried out as described [56] .
